Carries a conserved CRAL-TRIO domain. Its didtant homologs are cytoplasmic and are involved in antiviral response.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 30 |
NetGPI | no | yes: 0, no: 30 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HJI8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 313 | 317 | PF00656 | 0.351 |
CLV_NRD_NRD_1 | 245 | 247 | PF00675 | 0.268 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.254 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.323 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.318 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 247 | 251 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 258 | 262 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.466 |
CLV_PCSK_SKI1_1 | 288 | 292 | PF00082 | 0.372 |
CLV_PCSK_SKI1_1 | 73 | 77 | PF00082 | 0.268 |
DEG_COP1_1 | 313 | 323 | PF00400 | 0.256 |
DOC_CDC14_PxL_1 | 33 | 41 | PF14671 | 0.330 |
DOC_MAPK_DCC_7 | 32 | 41 | PF00069 | 0.345 |
DOC_MAPK_gen_1 | 20 | 28 | PF00069 | 0.457 |
DOC_MAPK_gen_1 | 246 | 252 | PF00069 | 0.278 |
DOC_MAPK_gen_1 | 78 | 86 | PF00069 | 0.538 |
DOC_MAPK_MEF2A_6 | 156 | 164 | PF00069 | 0.314 |
DOC_MAPK_MEF2A_6 | 229 | 237 | PF00069 | 0.371 |
DOC_MAPK_MEF2A_6 | 32 | 41 | PF00069 | 0.381 |
DOC_PP1_RVXF_1 | 133 | 139 | PF00149 | 0.249 |
DOC_PP1_RVXF_1 | 286 | 292 | PF00149 | 0.283 |
DOC_PP4_FxxP_1 | 63 | 66 | PF00568 | 0.281 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.448 |
DOC_WW_Pin1_4 | 184 | 189 | PF00397 | 0.305 |
DOC_WW_Pin1_4 | 273 | 278 | PF00397 | 0.306 |
DOC_WW_Pin1_4 | 289 | 294 | PF00397 | 0.423 |
DOC_WW_Pin1_4 | 304 | 309 | PF00397 | 0.436 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.520 |
DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.520 |
LIG_14-3-3_CanoR_1 | 229 | 237 | PF00244 | 0.376 |
LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.694 |
LIG_14-3-3_CanoR_1 | 300 | 308 | PF00244 | 0.305 |
LIG_14-3-3_CanoR_1 | 73 | 82 | PF00244 | 0.388 |
LIG_Actin_WH2_2 | 230 | 248 | PF00022 | 0.159 |
LIG_BIR_III_2 | 57 | 61 | PF00653 | 0.355 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.487 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.467 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.633 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.434 |
LIG_FHA_1 | 230 | 236 | PF00498 | 0.315 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.502 |
LIG_FHA_2 | 308 | 314 | PF00498 | 0.226 |
LIG_LIR_Apic_2 | 155 | 160 | PF02991 | 0.241 |
LIG_LIR_Apic_2 | 62 | 66 | PF02991 | 0.290 |
LIG_LIR_Gen_1 | 241 | 250 | PF02991 | 0.172 |
LIG_LIR_Nem_3 | 241 | 245 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 259 | 264 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 8 | 14 | PF02991 | 0.597 |
LIG_LYPXL_yS_3 | 11 | 14 | PF13949 | 0.349 |
LIG_PCNA_PIPBox_1 | 192 | 201 | PF02747 | 0.281 |
LIG_PTB_Apo_2 | 66 | 73 | PF02174 | 0.251 |
LIG_PTB_Phospho_1 | 66 | 72 | PF10480 | 0.249 |
LIG_SH2_CRK | 157 | 161 | PF00017 | 0.416 |
LIG_SH2_CRK | 284 | 288 | PF00017 | 0.351 |
LIG_SH2_CRK | 33 | 37 | PF00017 | 0.445 |
LIG_SH2_CRK | 72 | 76 | PF00017 | 0.334 |
LIG_SH2_GRB2like | 163 | 166 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 338 | 342 | PF00017 | 0.295 |
LIG_SH2_STAT3 | 263 | 266 | PF00017 | 0.159 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.285 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.207 |
LIG_SH2_STAT5 | 323 | 326 | PF00017 | 0.396 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.558 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.374 |
LIG_SH3_1 | 32 | 38 | PF00018 | 0.312 |
LIG_SH3_3 | 125 | 131 | PF00018 | 0.505 |
LIG_SH3_3 | 271 | 277 | PF00018 | 0.383 |
LIG_SH3_3 | 32 | 38 | PF00018 | 0.410 |
LIG_SUMO_SIM_par_1 | 230 | 236 | PF11976 | 0.368 |
LIG_SUMO_SIM_par_1 | 270 | 276 | PF11976 | 0.220 |
LIG_TRAF2_1 | 16 | 19 | PF00917 | 0.358 |
LIG_TYR_ITIM | 161 | 166 | PF00017 | 0.410 |
LIG_UBA3_1 | 25 | 32 | PF00899 | 0.508 |
MOD_CDC14_SPxK_1 | 65 | 68 | PF00782 | 0.257 |
MOD_CDK_SPxK_1 | 62 | 68 | PF00069 | 0.272 |
MOD_CK1_1 | 109 | 115 | PF00069 | 0.482 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.285 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.292 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.458 |
MOD_GlcNHglycan | 170 | 174 | PF01048 | 0.227 |
MOD_GlcNHglycan | 302 | 305 | PF01048 | 0.431 |
MOD_GlcNHglycan | 335 | 338 | PF01048 | 0.444 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.599 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.416 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.359 |
MOD_N-GLC_1 | 52 | 57 | PF02516 | 0.687 |
MOD_N-GLC_2 | 69 | 71 | PF02516 | 0.243 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.498 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.347 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.338 |
MOD_NEK2_1 | 227 | 232 | PF00069 | 0.323 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.341 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.346 |
MOD_NEK2_1 | 74 | 79 | PF00069 | 0.454 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.334 |
MOD_PKA_1 | 20 | 26 | PF00069 | 0.262 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.472 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.689 |
MOD_PKA_2 | 228 | 234 | PF00069 | 0.409 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.654 |
MOD_Plk_4 | 229 | 235 | PF00069 | 0.357 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.592 |
MOD_ProDKin_1 | 184 | 190 | PF00069 | 0.305 |
MOD_ProDKin_1 | 273 | 279 | PF00069 | 0.306 |
MOD_ProDKin_1 | 289 | 295 | PF00069 | 0.423 |
MOD_ProDKin_1 | 304 | 310 | PF00069 | 0.436 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.529 |
MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.515 |
MOD_SUMO_rev_2 | 17 | 23 | PF00179 | 0.383 |
TRG_DiLeu_BaEn_1 | 297 | 302 | PF01217 | 0.367 |
TRG_DiLeu_BaLyEn_6 | 35 | 40 | PF01217 | 0.490 |
TRG_DiLeu_LyEn_5 | 297 | 302 | PF01217 | 0.338 |
TRG_ENDOCYTIC_2 | 11 | 14 | PF00928 | 0.559 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.376 |
TRG_ENDOCYTIC_2 | 163 | 166 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 209 | 212 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 284 | 287 | PF00928 | 0.366 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.334 |
TRG_ER_diArg_1 | 78 | 80 | PF00400 | 0.295 |
TRG_NES_CRM1_1 | 83 | 97 | PF08389 | 0.216 |
TRG_Pf-PMV_PEXEL_1 | 258 | 262 | PF00026 | 0.397 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6D4 | Leptomonas seymouri | 39% | 66% |
A0A0N0P991 | Leptomonas seymouri | 30% | 73% |
A0A0N0P9K9 | Leptomonas seymouri | 26% | 72% |
A0A0N1I2J8 | Leptomonas seymouri | 41% | 75% |
A0A0N1PCS4 | Leptomonas seymouri | 49% | 75% |
A0A0S4INM2 | Bodo saltans | 22% | 85% |
A0A0S4J7N0 | Bodo saltans | 26% | 93% |
A0A0S4KJL3 | Bodo saltans | 29% | 76% |
A0A1X0NUJ5 | Trypanosomatidae | 30% | 74% |
A0A3Q8ICN0 | Leishmania donovani | 51% | 70% |
A0A3Q8IGQ2 | Leishmania donovani | 31% | 73% |
A0A3S7X4P4 | Leishmania donovani | 41% | 67% |
A0A3S7X4R1 | Leishmania donovani | 76% | 71% |
A0A422P1E3 | Trypanosoma rangeli | 31% | 75% |
A4HJI7 | Leishmania braziliensis | 41% | 100% |
A4HJI9 | Leishmania braziliensis | 50% | 98% |
A4HKB3 | Leishmania braziliensis | 29% | 73% |
A4HKB4 | Leishmania braziliensis | 24% | 71% |
A4I6Y2 | Leishmania infantum | 40% | 67% |
A4I6Y3 | Leishmania infantum | 76% | 71% |
A4I6Y4 | Leishmania infantum | 51% | 98% |
A4I7U3 | Leishmania infantum | 31% | 73% |
E9B204 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 67% |
E9B205 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 71% |
E9B206 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 50% | 98% |
E9B2Q1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 73% |
O76054 | Homo sapiens | 22% | 86% |
P58875 | Bos taurus | 22% | 86% |
Q10137 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 24% | 100% |
Q4Q5F6 | Leishmania major | 32% | 73% |
Q4Q655 | Leishmania major | 49% | 100% |
Q4Q656 | Leishmania major | 76% | 100% |
Q4Q657 | Leishmania major | 40% | 100% |
Q99J08 | Mus musculus | 22% | 86% |
Q99MS0 | Rattus norvegicus | 22% | 86% |
Q9UDX3 | Homo sapiens | 24% | 86% |
V5BL84 | Trypanosoma cruzi | 27% | 75% |